William J. Golden
Fondateur chez Lancet Capital Partners LLC
Profil
Mr. William J.
Golden is a Managing Director & Co-Founder at Lancet Capital Partners LLC.
Mr. Golden was previously employed as a Chairman by Noveome Biotherapeutics, Inc., a Management Consultant by Arthur D.
Little, Inc., and a Chief Financial Officer by VivoQuest, Inc. He also served on the board at Boston University Community Technology Fund and Boston University Office of Technology Development.
He received his undergraduate degree from the University of Notre Dame and an MBA from Harvard University.
Postes actifs de William J. Golden
| Sociétés | Poste | Début |
|---|---|---|
Lancet Capital Partners LLC
 Lancet Capital Partners LLC Investment ManagersFinance Lancet Capital Partners LLC (Lancet Capital Partners) is a venture capital firm founded in 1998 by William J. Golden and George L. Sing. The firm is headquartered in Pittsburgh, Pennsylvania. | Fondateur | 01/07/1997 |
Anciens postes connus de William J. Golden
| Sociétés | Poste | Fin |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Directeur Général | 01/01/2022 |
Boston University Office of Technology Development
 Boston University Office of Technology Development Investment ManagersFinance The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies | Corporate Officer/Principal | 31/12/1997 |
Boston University Technology Development Fund
 Boston University Technology Development Fund Investment ManagersFinance Boston University Community Technology Fund invests in companies located in the US. The fund targets companies operating in the fields of technology and life science companies. It provides financing for seed and early stage capital requirements with an investment size in the range of $0.5 - $1 million. It invests in venture capital funds and also makes co-investments. | Consultant / Advisor | 01/07/1997 |
VivoQuest, Inc.
 VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Directeur Financier/CFO | - |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de William J. Golden
| University of Notre Dame | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
Boston University Office of Technology Development
Boston University Office of Technology Development Investment ManagersFinance The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies | Finance |
Boston University Technology Development Fund
Boston University Technology Development Fund Investment ManagersFinance Boston University Community Technology Fund invests in companies located in the US. The fund targets companies operating in the fields of technology and life science companies. It provides financing for seed and early stage capital requirements with an investment size in the range of $0.5 - $1 million. It invests in venture capital funds and also makes co-investments. | Finance |
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
Lancet Capital Partners LLC
Lancet Capital Partners LLC Investment ManagersFinance Lancet Capital Partners LLC (Lancet Capital Partners) is a venture capital firm founded in 1998 by William J. Golden and George L. Sing. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
